chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Long line of itchy burning rash / Worse that the original shingles/Iitching at the site; My immune system went into overdrive; Low fever; Long line of itchy burning rash / Worse that the original shingles/ Burning / at the site; Felt sick for over a month; This case was reported by a consumer via interactive digital media and described the occurrence of itchy rash in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included shingles vaccine (1st dose received on an unknown date, non- gsk vaccine). Concurrent medical conditions included pain.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced itchy rash, immune system disorder, sickness, fever and burning sensation. On an unknown date, the outcome of the itchy rash, immune system disorder, sickness, fever and burning sensation were unknown.   It was unknown if the reporter considered the itchy rash, immune system disorder, sickness, fever and burning sensation to be related to Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported. The age group was not reported but selected adult as per vaccine indication. The patient had shingles along the ribs on right side. It was caught early and had the oral medicines and than received the first vaccine. The patient was still having pain so when the new vaccine came, the patient received it. This was about 4 years after the original shingles outbreak. On the third day after the shot, the patient actually broke out with a long line of itchy burning rash, it was worse that the original shingles. The patient's doctor told to not to get the booster shot as patient's immune system went into overdrive. The patient felt sick for over a month with low fever and burning and itching at the site. The patient had been dealing with this now for about 4 years and at least twice a month it will itch and burn in that same area but no rash. The patient guess it would never go completely away and learned to grin and bear it. The patient did not consented to follow up.
painful next day. Thirty hours after injection started to get red and itch. Their were 2 small areas about 1 inch in diameter. On April 12th the area was bigger about 4 inches in diameter and red. On April 13th it started itching in the morning and by afternoon was bright red and 6 inches in diameter including going down the inside of my arm. At this point the area went from just below injection site to the crease in my elbow and about 3 inches down the inside to the crease in my arm
Tingling on of the hands; This tingling sensation is worst when she put her hands under water; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on of the hands) and CONDITION AGGRAVATED (This tingling sensation is worst when she put her hands under water) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PARAESTHESIA (Tingling on of the hands) and CONDITION AGGRAVATED (This tingling sensation is worst when she put her hands under water). At the time of the report, PARAESTHESIA (Tingling on of the hands) and CONDITION AGGRAVATED (This tingling sensation is worst when she put her hands under water) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication information was provided.  No treatment medication information was provided.
I received my shot at about 1 p.m. on Sept. 4, at a pharmacy. When I returned home, I began noticing unusual brain fog and fatigue around 5 p.m., which quickly led to dizziness and fainting. Once the dizziness and fainting occurred, I began sweating profusely. I laid down in front of a fan and increased hydrating with water and juices. I continued to experience brain fog and mild light headedness the following day (Sept. 5), before it seemed to subside later that evening.
On 8/01, onset of joint pain, worse in knees. No redness or swelling of joints. Wrist and ankle pain is intermittent; knee pain all day. Rx: for Bextra 8/19/02. No med prior. Had 2nd (LY116A2) and 3rd (LY128A2) Lymerix.
Colds; sinus stuff going on; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "not recovered", described as "Colds"; SINUS DISORDER (non-serious), outcome "not recovered", described as "sinus stuff going on ". Therapeutic measures were taken as a result of nasopharyngitis, sinus disorder.  Additional information: The patient was on an antibiotic.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
temple headache seemed worse after first vaccine; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received first dose of bnt162b2 (BNT162B2, Lot number: EN6208), via an unspecified route of administration, administered in left arm on 12Mar2021 15:00 as single dose for covid-19 immunisation. Medical history included overweight and seasonal allergies, temple headaches, blood pressure high. Concomitant medication includes Hydrochlorothizide for blood pressure. Patient got the first COVID vaccine on 12Mar2021, and on the 17Mar2021, she went to get her blood work showed her platelet count was down to 148. It was supposed to be 150. Patient had temple headache before first dose, but they seemed worse after first vaccine. Event outcome was unknown.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021452953 same reporter/ patient/ vaccine, different dose/ AE
Pain at the injection site; A kind of "ball" at the injection site; The vaccine "did not enter at all" into the muscle; A spontaneous report was received from a consumer concerning a 57 year old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site pain, injection site induration and incorrect route of product administration.   The patient's medical history, was not provided by the reporter.No concomitant medications were reported.   On 11 Jan 2021, about 7 days  prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot #:unknown) through  an unknown route in the right arm for prophylaxis of COVID-19 infection.   On 17 Jan 2021, patient experienced pain at the injection site, a kind of ball at the injection site and said that it felt  like the vaccine"did not enter at all" into the muscle.   No treatment information was included.   Patient had low blood cell count.  Action taken with mRNA-1273 in response to the events was not applicable  The events, pain at the injection site, a kind of ball at the injection site and the vaccine did not enter in to the muscle were considered as unknown.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # unknown) with associated injection site pain and injection site induration
Fever 102.3, shaking, staring, hallucinating, incontinence.
severe nausea; severe vomiting; fever; headache; diarrhea; This is a spontaneous report from a contactable other healthcare professional. A 48-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 27Mar2021 at 14:00 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. No medical history was reported. The patient had no allergies to medications, food, or other products. Concomitant medications included emtricitabine, tenofovir alafenamide fumarate (DESCOVY), for unknown indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 06Mar2021 at 14:00 (at the age of 48-year-old), as a single dose for COVID-19 immunisation.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021 at 17:00, the patient experienced severe nausea, and vomiting 48 hours after vaccine, fever, headache and diarrhea. Therapeutic measures were taken as a result of events and included treatment with ZOFRAN, TYLENOL, rest, oral hydration. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of events, severe nausea, vomiting, fever, headache and diarrhea were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient presented to ED with progressively worsening history of nausea, vomiting, diarrhea. Patient was seen at different ED on 4/17 for similar complaints, admitted to their hospital, and discharged home last night. She has not been able to tolerate oral intake. Also has developing cellulitis of the lower abdomen. Also complains of fatigue and mild, dry cough. Patient was given fluids, GI cocktail, and ondansetron in ED. She was also given Percocet for pain control. The patient is being admitted to the hospital.
facial paralysis noted on 42nd day post 1st dose or 14th day post 2nd dose, Diagnosed as bells palsy in emergency department
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 23-MAY-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin) (strength and route were unknown) (lot#  N020620 and expiration date 22-JAN-2019) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
Patient phoned into to after hours phone nursing at 11/1/17 describing "upper buttock pain and pain in joints, wrists, ribs, kind of pain that makes you cry in church, feels like I have a terrible flu". Nurse noted: Temp 99, has not had any prednisone since yesterday am when he took his last 10 mg  (he gave impression he did not taper down like he was supposed to), started with 30 mg, tapered felt bad in years past has a flare when tapers but "not this bad" is wondering if having both immunizations put in the same arm made a problem, this am had his flu and pneumonia shots. Nurse also noted: "Reassured caller the fact the shots were given close together in the same arm would not cause a problem but he should follow up with his provider about the joint pain".  Patient called Dr.'s office 11/2/17 and noted the same the same symptoms. Provider advised patient to monitor symptoms, use Tylenol and ibuprofen PRN and follow up if needed. Patient contacted our office again on 11/3/17 and requested to speak to the nursing supervisor as he states the pharmacist advised him that two shots should not have been given in the same arm and that was why he was having the symptoms. Advised patient of administration recommendations with vaccines and he verbalized understanding but requests a VAERS report be placed to document his symptoms.
I received my first dose of the Pfizer COVID-19 Vaccine on 4/30/21.  I had began my menstrual cycle that week on 4/26.  I track every cycle with an app on my phone, and they are almost always 4-5 days long.  My cycle that week lasted 8 days, without any other abnormalities.  I received my second does of the Pfizer COVID-19 Vaccine on 5/21/21. My cycle on 5/23 was a typical 5 days.  My cycle on 6/20 however, was not.  On day 2, 6/21, I had an episode of extremely heavy bleeding that lasted around 3 hours.  Along with the heavy bleeding, I passed 4 large blood clots, around the size of a tampon. I felt light headed, crampy, and exhausted. I sought medical care through my regular doctor the next day, who sent me for labs which came out all normal.  I also went in for a well woman exam the following week, which also came back normal.
Tingling/itching sensation over right side of face and scalp, starting approximately 10 minutes after vaccination and lasting approximately 20 minutes. Resolved without treatment Intermittent, then sustained muscle soreness in the right arm starting approximately 6 hours after vaccination and lasting until approximately 48 hours after. Resolved without treatment. Fatigue the day following vaccination, and the day following that, but not on the day of vaccination. Resolved without treatment.
fever; chills; fatigue; a general feeling that I had been hit by a truck for 24-36 hours; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (167798). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1), for COVID-19 immunization, reaction(s): "little sore around the injection site". The following information was reported: PYREXIA (non-serious), outcome "recovered" (2021), described as "fever"; CHILLS (non-serious), outcome "recovered" (2021), described as "chills"; FATIGUE (non-serious), outcome "recovered" (2021), described as "fatigue"; FEELING ABNORMAL (non-serious), outcome "recovered" (2021), described as "a general feeling that I had been hit by a truck for 24-36 hours".  Additional information: I had been hit by a truck for 24-36 hours.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a healthcare worker concerning a female patient who on Dec 13 2005 was vaccinated IM with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). On the same day the patient developed an anaphylactic type reaction, which included red itchy rash at injection site, and swelling also at injection site. The patient was sent to the ER, treated with a steroid methylprednisolone (Medrol Dosepak) and released. The patients outcome was unknown. The reporter considered anaphylactic type reaction, red itchy rash at injection site, and swelling at injection site to be immediately life threatening, and to be other important medical events (OMIC). Additional information has been requested.
Approximately 90 minutes after vaccine was given, patient states that she began itching all over and by 4 1/2 hours after the vaccine was administered the itching became unbearable. Her face also became flushed.
pt recvd vax;body aches for 2-3 wks (moving around esp in back); inc t then terrible sore throat x 1 wk then 1 wk of laryngitis & complete deafness;
Fever, fussiness; jerking move, on and off for 3.5 to 4 hours. Received Tylenol for fever and then hospitalized on 6/15/06; discharged on 6/16/06.
Site: Pain at Injection Site-Medium, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: vasovagal reaction -Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hyperventilation-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Medium, Additional Details: patient started hyperventilationg after vaccine. Was flush and said dizzy. Had patient lay down said getting hot and sweaty. Then said having trouble breathing. Checked pulse rapid. BP was 168/92. Repeated that having problems breathing so called 911. They did EKG-normal, BP was back to normal after I laid her down,elevated feet, put fan on her, gave cold compress and had do breathing exercises. EMT after assessement and refused blood glucose test said probable vaso vagal rxn.
Fever; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (patient reported for herself). A non-pregnant female patient of an (Age: 40, Units: Unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on 08Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had fever in the evening on Mar2021 and took Tylenol for management caller asked if Tylenol will have an effect to the vaccine. Treatment was received for the event as Tylenol. The outcome of the events was reported as unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Headache, Myalgia, Arthralgia & Fever Narrative: Employee received first dose of Moderna vaccine on 08/19/2021 at 15:30. Reports symptoms began on 08/21/2021 in the afternoon, including injection site pain and swelling, fever, chills, joint pain, body aches, and fatigue. Reports used Dayquil and Nyquil for sumptom relief. Denies any previous reaction to a vaccine.
Information has been received from a consumer concerning her daughter who sometime in July 2007, was vaccinated with a first dose of Gardasil.  Subsequently, 4 days later, the patient broke out in a rash.  At the time of this report, the patient's outcome was unknown. No product quality complaint was involved.  Additional information has been requested.
Information has been received regarding a case in litigation concerning an approximately 3 year old male patient with idiopathic thrombocytopenic purpura who on 6/29/87 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine. On 8/7/87, the patient's spleen was removed to address his idiopathic thrombocytopenic purpura condition. Despite seeing several doctors for various reasons in subsequent years, including while at times febrile, the patient did not receive any follow up or revaccination, either with his family practice provider or the local hospital. On 9/19/00 at the age of 16 years, the patient died from fulminate pneumococcal infection. Upon internal review, worsening of idiopathic thrombocytopenic purpura was considered to be an other important medical event (OMIC).
Fever, coughing up mucus, extreme fatigue, chest pain trouble breathing/respiratory infection
Information has been received from 2 pharmacists referring to an unspecified patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 07-JUL-2016, the patient was vaccinated with a dose of expired PNEUMOVAX23 (lot # K023328, expiration date 23-JUN-2016, route not reported). No adverse effect was reported. Additional information has been requested.
Information has been received from a registered medical assistant referring to an unspecified number of patients of unknown age and gender. On an unknown date in 2015, the patients were vaccinated with improperly stored M-M-R II (dose, strength and route were not reported, lot# K021152). The temperature was possible out of range by 2 degrees to 3 degrees for short periods of time over a couple of days in April 2015. No adverse events were reported. This case is one of several cases received from the same source. Additional information has been requested. This case was initially received on 28-MAY-2015 and reported in 1506USA000575. 1506USA000575 has been deleted upon the follow up information received on 01-JUL-2015, in which the medical assistant stated no incorrect product storage happened. Now, case was re-created due to new follow up information was received from the medical assistant on 13-AUG-2015 and incorrect product storage was confirmed.
Redness, swelling, induration from 10-20 cm locally only, with pain and pruritus.
Red rash between breasts, on the left side of my left breast; Red rash around the sides of my neck; Painful large swelling in area of underarm; Painful large swelling in area left breast; Not just slightly enlarged lymph node; But the tissue of my underarm is swollen; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 26Apr2021 at 14:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic rash and swelling (got tested but they couldn't determine the cause) from 2015 and unknown if ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included Ibuprofen (ADVIL), taken for an unknown indication from an unknown start date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 14:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 the patient experienced red rash between breasts, around the sides of the neck, on the left side of the left breast, painful large swelling in area of underarm and left breast. Not just slightly enlarged lymph node, but the tissue of the underarm was swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red rash between breasts, around the sides of the neck, on the left side of the left breast, painful large swelling in area of underarm and left breast, slightly enlarged lymph node and swollen tissue of the underarm was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Had chills for about 24 hours and a headache for about 36 hours. Also had a sore arm.
pt recv vax 5JUL96 9AM & 905AM pt left shot room;906AM pt found face down in waiting room on floor;@ this time pupils were fixed & dilated, tremors to all 4 extremities & unresponsive to verbal command x 45sec;ecchymotic area on lt cheek